MEDICAL RECOMMENDATIONS

Archived 35: NACI statement: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age [2022-03-17]

National Advisory Committee on ImmunizationImmunization2022Archived document

ASEM documentary overview

Official National Advisory Committee on Immunization document (2022) on “Archived 35: NACI statement: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age [2022-03-17]”. NACI recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age: methods, vaccine recommendations, schedule, clinical trial data and solicited adverse events following immunization for COVID-19.

This overview helps you identify the document. Always consult the current official publication for clinical recommendations.

Official document